CASI PHARMACEUTICALS, INC. Payments to Acquire Equity Method Investments
CASI PHARMACEUTICALS, INC. (CASIF) reported Payments to Acquire Equity Method Investments of $1.62 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2026-05-15
| Period end | Payments to Acquire Equity Method Investments 12 month |
|---|---|
| 2025-12-31 | $1.62M 20-F · filed 2026-05-15 |
| 2024-12-31 | $1.37M 20-F · filed 2026-05-15 |